Pure Financial Advisors LLC Buys Shares of 21,077 Leidos Holdings, Inc. $LDOS

Pure Financial Advisors LLC purchased a new position in Leidos Holdings, Inc. (NYSE:LDOS) during the 2nd quarter, Holdings Channel.com reports. The firm purchased 21,077 shares of the aerospace company’s stock, valued at approximately $2,170,000.

Other large investors have also added to or reduced their stakes in the company. Bryn Mawr Trust Advisors LLC increased its holdings in shares of Leidos by 4.8% during the fourth quarter. Bryn Mawr Trust Advisors LLC now owns 1,337 shares of the aerospace company’s stock valued at $241,000 after acquiring an additional 61 shares in the last quarter. Cullen Frost Bankers Inc. raised its holdings in Leidos by 19.4% in the 4th quarter. Cullen Frost Bankers Inc. now owns 381 shares of the aerospace company’s stock worth $69,000 after acquiring an additional 62 shares during the last quarter. Keybank National Association OH lifted its position in Leidos by 3.6% during the fourth quarter. Keybank National Association OH now owns 1,855 shares of the aerospace company’s stock valued at $335,000 after purchasing an additional 65 shares during the period. Glenmede Investment Management LP grew its position in Leidos by 3.2% during the third quarter. Glenmede Investment Management LP now owns 2,240 shares of the aerospace company’s stock valued at $423,000 after buying an additional 69 shares during the period. Finally, HighPoint Advisor Group LLC increased its holdings in Leidos by 0.9% during the fourth quarter. HighPoint Advisor Group LLC now owns 7,635 shares of the aerospace company’s stock valued at $1,377,000 after buying an additional 70 shares during the last quarter. Hedge funds and other institutional investors own 76.12% of the company’s stock.

Insiders Place Their Bets

In other Leidos news, Director Noel B. Geer sold 10,000 shares of Leidos stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $140.66, for a total value of $1,406,600.00. Following the sale, the director owned 34,274 shares of the company’s stock, valued at $4,820,980.84. The trade was a 22.59% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.77% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

LDOS has been the topic of several analyst reports. JPMorgan Chase & Co. dropped their price target on shares of Leidos from $210.00 to $160.00 and set an “overweight” rating on the stock in a research note on Monday, July 13th. BNP Paribas Exane lifted their target price on Leidos from $165.00 to $175.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Citigroup boosted their price target on Leidos from $138.00 to $161.00 and gave the company a “buy” rating in a report on Tuesday, August 11th. TD Cowen raised their price objective on Leidos from $115.00 to $135.00 and gave the stock a “hold” rating in a research note on Friday, August 7th. Finally, Bank of America reiterated a “neutral” rating and set a $125.00 price objective (down from $200.00) on shares of Leidos in a research note on Wednesday, June 17th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and ten have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $162.93.

Leidos Stock Performance

NYSE:LDOS opened at $137.47 on Thursday. The stock has a 50-day moving average price of $118.57 and a 200 day moving average price of $139.79. The stock has a market capitalization of $17.25 billion, a P/E ratio of 12.82, a P/E/G ratio of 1.96 and a beta of 0.52. Leidos Holdings, Inc. has a 12-month low of $98.86 and a 12-month high of $205.77. The company has a current ratio of 1.63, a quick ratio of 1.60 and a debt-to-equity ratio of 1.13.

Leidos (NYSE:LDOS) last announced its quarterly earnings data on Tuesday, August 4th. The aerospace company reported $3.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.91 by $0.35. Leidos had a net margin of 7.80% and a return on equity of 30.81%. The business had revenue of $4.56 billion during the quarter, compared to analyst estimates of $4.44 billion. During the same period last year, the firm posted $3.21 EPS. The company’s revenue was up 7.2% on a year-over-year basis. Leidos has set its FY 2026 guidance at 12.200-12.500 EPS. Equities research analysts forecast that Leidos Holdings, Inc. will post 12.38 EPS for the current fiscal year.

Leidos declared that its board has approved a stock buyback plan on Friday, July 31st that allows the company to buyback 20,000,000 shares. This buyback authorization allows the aerospace company to reacquire shares of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s leadership believes its shares are undervalued.

Leidos Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be paid a dividend of $0.43 per share. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $1.72 dividend on an annualized basis and a yield of 1.3%. Leidos’s dividend payout ratio is presently 16.04%.

Leidos Profile

Leidos is an American technology and engineering company that provides services and solutions to government and commercial customers, with a strong focus on national security, defense, intelligence, and civil government markets. The company delivers systems integration, engineering, cybersecurity, software development, data analytics, cloud migration and managed IT services, as well as mission support for complex programs. Leidos’ work spans areas such as C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance), secure communications, sensors and systems engineering, and health IT solutions for public-sector healthcare programs.

Leidos traces its corporate roots to Science Applications International Corporation (SAIC) and emerged as an independent, publicly traded company following a corporate separation in 2013.